Prof Sandro Porceddu
Honorary Professorial Fellow
Department of Radiology
270 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
Clinical and Patient-Reported Outcomes (PROs) in C-POST: Phase 3 Trial of Adjuvant Cemiplimab (Cemi) vs Placebo (Pbo) for High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)
DOI: 10.1016/j.ijrobp.2026.02.1432026
Journal article
Clinical and Patient-Reported Outcomes in C-POST: Phase 3 Trial of Adjuvant Cemiplimab versus Placebo for High-Risk Cutaneous Squamous Cell Carcinoma
DOI: 10.1016/j.ejcskn.2026.1009622026
Journal article
Radiation Therapy Target Objectives for Tonsillar Cancer Treated With Unilateral Radiation Therapy—a Replanning Study From TROG 12.01
DOI: 10.1016/j.ijrobp.2025.12.0582026
Journal article
The impact of dysphagia on carers of people with head and neck cancer: development and preliminary validation of the significant other scale for eating in head and neck cancer (SOSE-H&N)
DOI: 10.1080/09638288.2025.25945752026
Journal article
Comparison of Prophylactic Versus Reactive Tube Feeding Approaches on Weight Loss and Unplanned Hospital Admissions in Patients with Head and Neck Cancer Receiving Chemoradiotherapy
DOI: 10.3390/curroncol330100052025
Research grants (ARC, NHMRC, MRFF)
Novel Treatment of Radiation Associated Dysphagia With Statins (TRADstat)
2024
Research grants (other domestic)
Next-Generation Radiotherapy Treatment Planning With Artificial Intelligence
RECENT SCHOLARLY WORKS
2026
Journal article
A deep learning approach for predicting linear accelerator output settings in automated radiotherapy planning of oligometastatic cancer
DOI: 10.1016/j.phro.2025.1008902026
Journal article
Sensorineural hearing outcomes in HPV-positive oropharyngeal cancer: a secondary analysis of the TROG 12.01 randomized trial (SHOUT)
DOI: 10.1016/j.radonc.2026.1115502025
Journal article
Étude randomisée de phase 3 comparant le cémiplimab adjuvant à un placebo et analyse des tumeurs primaires secondaires (TPS) dans le carcinome épidermoïde cutané à haut risque (CEC) : l’essai C-POST
DOI: 10.1016/j.fander.2025.09.6282025
Journal article
Radiation Therapy Utilization for Primary Cutaneous T-Cell Lymphoma Is Lowest Among Patients Living in the Most Geographically Accessible Areas: An Australian Study
DOI: 10.1016/j.ijrobp.2025.07.0542025
Journal article
The authors reply
DOI: 10.1056/NEJMc2513309